| Gene Symbol | PLAU |
| Entrez Gene ID | 100008633 |
| Full Name | plasminogen activator, urokinase |
| Gene Type | protein-coding |
| Organism | Oryctolagus cuniculus(rabbit) |
IVD Raw Materials
ORF » Species Summary » Oryctolagus cuniculus » PLAU cDNA ORF clone
| Gene Symbol | PLAU |
| Entrez Gene ID | 100008633 |
| Full Name | plasminogen activator, urokinase |
| Gene Type | protein-coding |
| Organism | Oryctolagus cuniculus(rabbit) |
| mRNA | Protein | Name |
|---|---|---|
| XM_008269903.2 | XP_008268125.1 | urokinase-type plasminogen activator isoform X1 |
| NM_001082011.1 | NP_001075480.1 | urokinase-type plasminogen activator precursor |
Immunohistochemical profile of NF-κB/p50, NF-κB/p65, MMP-9, MMP-2, and u-PA in experimental cervical spondylotic myelopathy.
Karadimas SK, Klironomos G, Papachristou DJ, Papanikolaou S, Papadaki E, Gatzounis G
Spine38(1)4-10(2013 Jan)
Constriction of carotid arteries by urokinase-type plasminogen activator requires catalytic activity and is independent of NH(2)-terminal domains.
Massey PG, Tanaka S, Buckler JM, Jiang B, McCourtie A, Qian K, Tom C, Stempien-Otero A, Wen S, Luttrell I, Chitaley K, Dichek DA
Thrombosis and haemostasis102(5)983-92(2009 Nov)
Downregulation of urokinase-type and tissue-type plasminogen activators in a rabbit model of renal ischemia/reperfusion.
Sugiki M, Omura S, Yoshida E, Itoh H, Kataoka H, Maruyama M
Journal of biochemistry132(3)501-8(2002 Sep)
Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth.
Falkenberg M, Tom C, DeYoung MB, Wen S, Linnemann R, Dichek DA
Proceedings of the National Academy of Sciences of the United States of America99(16)10665-70(2002 Aug)
Temporal alterations in mRNA levels for proteinases and inhibitors and their potential regulators in the healing medial collateral ligament.
Reno C, Boykiw R, Martinez ML, Hart DA
Biochemical and biophysical research communications252(3)757-63(1998 Nov)
GeneRIFs: Gene References Into Functions What's a GeneRIF?
The following PLAU gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the PLAU cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.
| CloneID | OOb00171 | |
| Clone ID Related Accession (Same CDS sequence) | XM_008269903.2 , NM_001082011.1 | |
| Accession Version | NM_001082011.1 Latest version! | Documents for ORF clone product in default vector |
| Sequence Information | ORF Nucleotide Sequence (Length: 1302bp) Protein sequence SNP |
|
| Vector | pcDNA3.1-C-(k)DYK or customized vector | User Manual |
| Clone information | Clone Map | MSDS |
| Tag on pcDNA3.1+/C-(K)DYK | C terminal DYKDDDDK tags | |
| ORF Insert Method | CloneEZ™ Seamless cloning technology | |
| Insert Structure | linear | |
| Update Date | 1562256000000 | |
| Organism | Oryctolagus cuniculus(rabbit) | |
| Product | urokinase-type plasminogen activator precursor | |
| Comment | Comment: PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence was derived from AB087224.1. ##Evidence-Data-START## Transcript exon combination :: AB087224.1, AY122285.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMN03328715, SAMN03328716 [ECO:0000348] ##Evidence-Data-END## | |
1 | ATGAGAGTCC TCCTGGTATG CCTGCTTCTC TGCGCCCTGG TCGTGAGCGA CTCCGAAGGA |
The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
| RefSeq | NP_001075480.1 |
| CDS | 128..1429 |
| Translation |
Target ORF information:
Target ORF information:
|
NM_001082011.1 |
1 | ATGAGAGTCC TCCTGGTATG CCTGCTTCTC TGCGCCCTGG TCGTGAGCGA CTCCGAAGGA |
The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
| CloneID | OOb00171 | |
| Clone ID Related Accession (Same CDS sequence) | XM_008269903.2 , NM_001082011.1 | |
| Accession Version | XM_008269903.2 Latest version! | Documents for ORF clone product in default vector |
| Sequence Information | ORF Nucleotide Sequence (Length: 1302bp) Protein sequence SNP |
|
| Vector | pcDNA3.1-C-(k)DYK or customized vector | User Manual |
| Clone information | Clone Map | MSDS |
| Tag on pcDNA3.1+/C-(K)DYK | C terminal DYKDDDDK tags | |
| ORF Insert Method | CloneEZ™ Seamless cloning technology | |
| Insert Structure | linear | |
| Update Date | 1466524800000 | |
| Organism | Oryctolagus cuniculus(rabbit) | |
| Product | urokinase-type plasminogen activator isoform X1 | |
| Comment | Comment: MODEL REFSEQ: This record is predicted by automated computational analysis. This record is derived from a genomic sequence (NC_013686.1) annotated using gene prediction method: Gnomon, supported by mRNA evidence. Also see: Documentation of NCBI's Annotation Process On Jun 23, 2016 this sequence version replaced XM_008269903.1. ##Genome-Annotation-Data-START## Annotation Provider :: NCBI Annotation Status :: Full annotation Annotation Version :: Oryctolagus cuniculus Annotation Release 102 Annotation Pipeline :: NCBI eukaryotic genome annotation pipeline Annotation Software Version :: 7.1 Annotation Method :: Best-placed RefSeq; Gnomon Features Annotated :: Gene; mRNA; CDS; ncRNA ##Genome-Annotation-Data-END## | |
1 | ATGAGAGTCC TCCTGGTATG CCTGCTTCTC TGCGCCCTGG TCGTGAGCGA CTCCGAAGGA |
The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
| RefSeq | XP_008268125.1 |
| CDS | 51..1352 |
| Translation |
Target ORF information:
Target ORF information:
|
XM_008269903.2 |
1 | ATGAGAGTCC TCCTGGTATG CCTGCTTCTC TGCGCCCTGG TCGTGAGCGA CTCCGAAGGA |
The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
Immunohistochemical profile of NF-κB/p50, NF-κB/p65, MMP-9, MMP-2, and u-PA in experimental cervical spondylotic myelopathy. |
Constriction of carotid arteries by urokinase-type plasminogen activator requires catalytic activity and is independent of NH(2)-terminal domains. |
Downregulation of urokinase-type and tissue-type plasminogen activators in a rabbit model of renal ischemia/reperfusion. |
Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth. |
Temporal alterations in mRNA levels for proteinases and inhibitors and their potential regulators in the healing medial collateral ligament. |